References
- Bartalesi F, Spinicci M, Mencarini J, et al. The role of Quantiferon-TB Gold in-Tube in the diagnosis and treatment monitoring of active tuberculosis. Infect Dis (Lond). 2017;49:474–477.
- Qiagen. QuantiFERON®-TB Gold Plus (QFT®-Plus) ELISA Package Insert, 2017. [cited 2018 Dec 01]. Available from: http://www.quantiferon.com/wp-content/uploads/2017/10/QFT-Plus-ELISA-IFU-L1095849-R02.pdf
- Petruccioli E, Chiacchio T, Pepponi I, et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. J Infect. 2016;73:588–597.
- Day CL, Abrahams DA, Lerumo L, et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol. 2011;187:2222–2232.
- Rozot V, Vigano S, Mazza-Stalder J, et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol. 2013;43:1568–1577.
- Sester M, Sotgiu G, Lange C, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37:100–111.
- Knierer J, Gallegos Morales EN, Schablon A, et al. QFT-Plus: a plus in variability? – Evaluation of new generation IGRA in serial testing of students with a migration background in Germany. J Occup Med Toxicol. 2017;12:1-12.
- Tagmouti S, Slater M, Benedetti A, et al. Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. Ann Am Thorac Soc. 2014;11:1267–1276.